Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...
The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.
The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...
First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...